Category: Clinical Breakthroughs
-
Cellular Therapy Increases Survival in Recurring B-cell Lymphoma
A two-year follow-up clinical trial found that a personalized cellular therapy treatment for relapsed or refractory B-cell lymphoma demonstrated high safety and improved overall survival in patients, according to findings published in Blood.
-
Rethinking the Burden of Cancer Treatments’ Side Effects
Even mild and moderate side effects can contribute to patients with cancer discontinuing their treatment, according to an analysis recently published in the Journal of Clinical Oncology.
-
Human Longevity Lab Will Study Methods to Slow or Reverse Aging
Northwestern Medicine has launched the Human Longevity Laboratory, a longitudinal, cross-sectional study that will investigate the relationship between chronological age and biological age and validate interventions that may reverse or slow down the processes of aging.
-
Survey Shows Leadership and Peer Support Essential for Resident Success
Residents are more likely to flourish in their training programs and daily lives when peer-support is strong and leadership prioritizes residents’ wellbeing, according to results from a multi-institutional survey published in Annals of Internal Medicine.
-
Investigating Methods for Preventing Pancreatitis after Endoscopy
Anti-inflammatory drugs alone are not sufficient to prevent pancreas inflammation following a common endoscopic procedure, according to a study recently published in The Lancet.
-
As Patients Live Longer, New Criteria Needed for Prostate Cancer Trials
A lack of cancer progression could be used as a surrogate for overall survival in newly metastatic prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology.
-
New Anti-Blood Clotting Drug May Lower Risk of Recurrent Strokes
An experimental drug designed to block blood-clotting proteins may slightly lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology.
-
Experimental Drug May Slow Childhood Brain Tumors
The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.
-
New 3D Spatial Approach Reveals Interactive View of Glioblastoma and Therapeutic Targets
A multidisciplinary team of investigators has developed a first-of-its-kind interactive 3D spatial approach that reveals new therapeutic targets and provides a comprehensive three-dimensional view of glioblastoma tumors, detailed in a recent study published in Cell.
-
Nearly 40% of Type 2 Diabetes Patients Stop Taking Their Second-Line Medication
Nearly two-thirds of patients with diabetes either discontinued their second-line medication, switched to a different medication class or intensified their treatment, according to a recent study.
